Sign In
Buy ABT
$93.24
+2.73 (+3.02%)
At Close: Jun 25, 2026
Carl Abbott's “House of Columns” Brings Sarasota School Modernism to the Market on Longboat Key
11:32am, Tuesday, 17'th Feb 2026
LISTING LINK: https://www.premiersothebysrealty.com/single-family/mfr/a4681242/6610-gulf-of-mexico-drive-longboat-key-fl-34228 DROPBOX: https://tours.coastalhomephotography.net/public/vtour/display/23
Fifth Third Bancorp Sells 10,616 Shares of Abbott Laboratories $ABT
04:28am, Monday, 16'th Feb 2026
Fifth Third Bancorp lowered its stake in shares of Abbott Laboratories (NYSE: ABT) by 0.8% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commis
Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells
06:08pm, Sunday, 15'th Feb 2026
In the fourth quarter of 2025, the Baron Discovery Fund returned 0.19% (Institutional Shares), trailing the Russell 2000 Growth Index by 1.03%. In these periods, low quality (high debt and poor profit
Cidel Asset Management Inc. Grows Position in Abbott Laboratories $ABT
05:00am, Sunday, 15'th Feb 2026
Cidel Asset Management Inc. increased its position in shares of Abbott Laboratories (NYSE: ABT) by 2.0% in the undefined quarter, according to the company in its most recent filing with the Securities
Abbott Laboratories: A Key Reduction in Robert Bruce's Portfolio
06:01pm, Friday, 13'th Feb 2026
Exploring the Strategic Moves of a Seasoned Value Investor Robert Bruce (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, p
Abbott Labs Just Extended Its Dividend Aristocrat Status: What Comes Next?
01:04pm, Thursday, 12'th Feb 2026
Abbott Laboratories just paid its quarterly dividend of $0.63 per share on February 13, 2026, marking a 6.8% increase from the prior quarterly rate.
Caisse Des Depots ET Consignations Buys 9,374 Shares of Abbott Laboratories $ABT
06:21am, Thursday, 12'th Feb 2026
Caisse Des Depots ET Consignations raised its stake in Abbott Laboratories (NYSE: ABT) by 61.7% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commi
Abbott Labs: The Healthcare Dividend Stock I'd Happily Hold Forever
06:15am, Thursday, 12'th Feb 2026
This company has delivered earnings and dividend growth over time. Abbott's innovation and a new acquisition could spur more growth in the years to come.
Abbott Laboratories $ABT Shares Sold by Atria Investments Inc
04:01am, Thursday, 12'th Feb 2026
Atria Investments Inc lowered its stake in shares of Abbott Laboratories (NYSE: ABT) by 6.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commiss
S&CO Inc. Sells 16,992 Shares of Abbott Laboratories $ABT
03:46am, Tuesday, 10'th Feb 2026
S&CO Inc. trimmed its stake in Abbott Laboratories (NYSE: ABT) by 6.9% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund
Abbott Laboratories $ABT Shares Acquired by Rockland Trust Co.
03:46am, Tuesday, 10'th Feb 2026
Rockland Trust Co. increased its position in shares of Abbott Laboratories (NYSE: ABT) by 26.8% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commi
Financial Contrast: Glucose Health (OTCMKTS:GLUC) vs. Abbott Laboratories (NYSE:ABT)
01:56am, Monday, 09'th Feb 2026
Glucose Health (OTCMKTS:GLUC - Get Free Report) and Abbott Laboratories (NYSE: ABT - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesse
Diamond Hill Capital's Strategic Moves: HCA Healthcare Inc. Reduced by 1.25%
05:03pm, Friday, 06'th Feb 2026
Insight into Diamond Hill Capital (Trades, Portfolio)'s Fourth Quarter 2025 13F Filing Diamond Hill Capital (Trades, Portfolio) recently submitted its 13F fili
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
10:00am, Friday, 06'th Feb 2026
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Positive 12-month results from the VOLT-AF IDE Study presented at the AF Symposium and simultaneously published in JACC: Clinical Electrophysiology, reinforce the Volt™ Pulsed Field Ablation (PFA
